Thus, alleviation of TDP-43-mediated pathology could have broad implications for the treatment of different types of neurodegenerative diseases, at least those displaying typical TDP-43 pathological hallmarks such as increased gliosis and cytoplasmic mislocation of TDP-43. This evidence concerns the gene TARDBP and neurodegenerative disease.